home / stock / mnpr / mnpr news


MNPR News and Press, Monopar Therapeutics Inc. From 09/29/25

Stock Information

Company Name: Monopar Therapeutics Inc.
Stock Symbol: MNPR
Market: NASDAQ
Website: monopartx.com

Menu

MNPR MNPR Quote MNPR Short MNPR News MNPR Articles MNPR Message Board
Get MNPR Alerts

News, Short Squeeze, Breakout and More Instantly...

MNPR - Buy Recommendation Issued On MNPR By H.C. Wainwright

2025-09-29 09:15:09 ET H.C. Wainwright analyst issues BUY recommendation for MNPR on September 29, 2025 12:13PM ET. The previous analyst recommendation was Buy. MNPR was trading at $76.63 at issue of the analyst recommendation. The overall analyst consensus : BUY. Cu...

MNPR - Monopar Therapeutics Inc. (NASDAQ: MNPR) Climbs to New 52-Week High

2025-09-25 10:05:21 ET Shares of Monopar Therapeutics Inc. (NASDAQ: MNPR) traded at a new 52-week high today and are currently trading at $72.41. So far today, approximately 9,340 shares have been exchanged, as compared to an average 30-day volume of 54,320 shares. Monopar Therapeut...

MNPR - US Companies Moving the Markets, Evening edition
Wed, Sep 24, 2025 as of 4:00 pm ET

A look at the top 10 most actives in the United States Youxin Technology Ltd (YAAS) rose 42.2% to $0.1062 on volume of 665,301,006 shares AtlasClear Holdings Inc. (ATCH) rose 67.5% to $0.67 on volume of 506,987,932 shares Opendoor Technologies Inc (OPEN) rose 16.1% to $8.23 on volume of 291...

MNPR - Monopar Therapeutics announces pricing of $135M offering

2025-09-24 00:18:40 ET More on Monopar Therapeutics Monopar Therapeutics: A Speculative Buy On 2 Fronts With Catalysts Imminent Monopar a new outperform at Oppenheimer on Wilson disease candidate Seeking Alpha’s Quant Rating on Monopar Therapeutics His...

MNPR - Monopar Therapeutics Inc. Announces Pricing of $135 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

WILMETTE, Ill., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) (“Monopar Therapeutics”, “Monopar”, or the “Company”), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical ...

MNPR - Monopar Announces Journal of Hepatology Publishes Physicians' Letter to the Editor Demonstrating ALXN1840 Rapidly Improved Copper Balance in Wilson Disease Patients

WILMETTE, Ill., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today announced that the Journ...

MNPR - Buy Recommendation Issued On MNPR By Lake Street

2025-09-23 09:00:03 ET Lake Street analyst issues BUY recommendation for MNPR on September 23, 2025 11:51AM ET. MNPR was trading at $63.66 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 8 - Buy, 2 - Hold...

MNPR - US Companies Moving the Markets, Evening edition
Wed, Sep 17, 2025 as of 4:00 pm ET

A look at the top 10 most actives in the United States Opendoor Technologies Inc (OPEN) rose 14.5% to $10.21 on volume of 693,402,479 shares AtlasClear Holdings Inc. (ATCH) rose 87.4% to $1.62 on volume of 232,378,338 shares NVIDIA Corporation (NVDA) fell 2.6% to $170.29 on volume of 210,26...

MNPR - Top Quant-rated nuclear energy stocks as group is best YTD performer

2025-09-15 10:48:41 ET More on the nuclear energy sector: NUKZ: The Energy Source That Will Power Artificial Intelligence NUKZ Can Provide Investors With A Differentiated Approach To Investing In The Nuclear Fuel Cycle NLR: Buy To Unleash The Power Of The Atom ...

MNPR - Monopar to Present New Long-Term Neurological Efficacy and Safety Data for ALXN1840 in Wilson Disease at the 150th American Neurological Association Annual Meeting

WILMETTE, Ill., Sept. 14, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today announced that new data on...

Previous 10 Next 10